Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picosecond Nd:YAG Laser vs Hydroquinone for Melasma
NCT03040089Completed
- Sponsor
- Lutronic
- Start
- Mar 2016
- Primary completion
- Jul 2016
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Lutronic. Primary endpoint: Success rate of treatment according to RL*I. Started Mar 2016; status: completed.
Beyond the preview
Go deeper on NCT03040089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03040089.